Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Evidence-based Guideline: Treatment of Parenchymal Neurocysticercosis
Neurol 80:1424-1429, Baird, R.,et al, 2013
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930, Engel, J.,et al, 2012
A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009
Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
Position Statement on the Coverage of Anticonvulsant Drugs for the Treatment of Epilepsy
Neurol 68:1249-1250,1245, Liow,K.,et al, 2007
Epilepsy in Children
Lancet 367:499-524, Guerrini,R., 2006
Adult Epilepsy
Lancet 367:1087-1100, Duncan,J.S.,et al, 2006
Epilepsy Syndromes in Infancy
Pediatr Neurol 34:253-263, Korff,C.M. &Nordii,D.R.,Jr., 2006
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Seizure Control and Mortality in Epilepsy
Ann Neurol 46:45-50, Sperling,M.R.,et al, 1999
Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999
If First AED Fails to Control Child's Epilepsy, What Are the Chances of Success with Next Drug
J Pediatr 131:821-824, 7941997., Camfield,P.R.,et al, 1997
The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
Epilepsy: New Advances
Lancet 385:884-898, Moshe, S.L.,et al, 2015
Substitution Monotherapy with Levetiracetam vs Older Antiepileptic Drugs
Arch Neurol 69:1563-1571, Hakami, T.,et al, 2012
The Outcome of Therapies in Refractory and Super-Refractory Convulsive Status Epilepticus and Recommendations for Therapy
BRAIN 135:2314-2328, Shorvon, S. & Ferlisi, M., 2012
Drug-Resistant Epilepsy
NEJM 365:919-26, Kwan, P.,et al, 2011
Comparative Effectiveness of 10 Antiepileptic Drugs in Older Adults With Epilepsy
Arch Neurol 67:408-415, Arif,H., et al, 2010
Seizure Relapse and Development of Drug Resistance Following Long-Term Seizure Remission
Arch Neurol 66:1233-1239, Schiller,Y., 2009
Initial Management of Epilepsy
NEJM 359:166-176, French,J.A. &Pedley,T.A., 2008
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Comparison of Levetiracetam and Controlled-Release Carbamazepine in Newly Diagnosed Epilepsy
Neurol 68:402-408, Brodie,M.J.,et al, 2007
Neonatal Seizures
Ann Neurol 62:112-120, Silverstein,F.S. &Jensen,F.E., 2007
Seizure Control and Treatment in Pregnancy, Observations from the EURAP Epilepsy Pregnancy Registry
Neurol 66:354-360, The EURAP Study Group, 2006
Safety and Efficacy of Buccal Midazolam Versus Rectal Diazepam for Emergency Treatment of Seizures in Children: A Randomised Controlled Trial
Lancet 366:205-210,182, McIntyre,J.,et al, 2005
Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter Gene ABCB1
NEJM 348:1442-1448,1480, Siddiqui,A.,et al, 2003
Recent Advnaces in the Treatment of Epilepsy
Arch Neurol 60:929-935, Nguyen,D.K. &Spencer,S.S., 2003
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
A New Antiepileptic Drug
JNNP 72:426-429, Shorvon,S.D. &van Rijckevorsel,K., 2002
Evolving Treatment Strategies for Epilepsy
JAMA 287:2917-2920, Diaz-Arrastia,R.,et al, 2002
Oxcarbazepine (Trileptal) as Monotherapy in Patients with Partial Seizures
Neurol 57:864-871, Sachdeo,R.,et al, 2001
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000
Restrictions on the Availability of Antiepileptic Drugs
Arch Neurol 57:273-274,275, Bergen,D.C., 2000
Early Identification of Refracvtory Epilepsy
NEJM 342:314-319, Kwan,P.&Brodie,M.J., 2000
Management of Epilepsy in Adolescents and Adults
Lancet 356:323-329, Brodie,M.J. & French,J.A., 2000
Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999
Topiramate in Clinical Practice:First Year's Postlicensing Experience in a Specialist Epilepsy Clinic
JNNP 66:759-763, Kellett,M.W.,et al, 1999
Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999
Seizure Frequency and the Health-Related Quality of Life of Adults with epilepsy
Neurol 53:162-166, Leidy,N.K.,et al, 1999